Thomas C G, Rutledge R G
Ann Surg. 1981 Jun;193(6):769-76. doi: 10.1097/00000658-198106000-00013.
The incidence of chronic (Hashimoto's) thyroiditis in surgical specimens is relatively high, i.e., 13% in collected studies, for a disease with clinical and laboratory characteristics that are sufficiently specific, that thyroidectomy should rarely be required for diagnosis or treatment. This incidence is presumably related to the difficulty in distinguishing between thyroiditis and a thyroid neoplasm. Experience with 260 thyroidectomies at the North Carolina Memorial Hospital performed between 1875 and 1980 for a dominant thyroid mass was reviewed to determine the reliability of criteria for diagnosis and the indications for surgical treatment. Using the criteria of clinical findings, complemented by laboratory studies, e.g., free thyroxine index, thyroid autoantibodies, TSH level, thyroid scan, in addition to the judicious use of the cutting (core) needle biopsy procedure, the incidence of Hashimoto's thyroiditis in this series was 3% and cancer-27%. Four patients had Hashimoto's thyroiditis coincidental to another disease for which thyroidectomy was performed. In seven patients Hashimoto's thyroiditis alone constituted the indications for operation. The indications for operation in these patients were: autonomous function with mild hyperthyroidism (2 patients); associated cold nodule (2 patients); thyromegaly unresponsive to suppressive therapy (2 patients); and rapidly enlarging mass simulating a neoplasm (1 patient). Only one of 71 patients with well differentiated carcinoma had Hashimoto's thyroiditis. One patient with Hashimoto's thyroiditis had associated lymphoma. In most patients, Hashimoto's thyroiditis can be identified using appropriate clinical and laboratory criteria without resorting to thyroidectomy to differentiate between thyroiditis and a neoplasm. Operations are indicated in patients with suspected or established chronic thyroiditis for: 1) the presence of a dominant mass with incomplete regression on suppressive therapy. 2) Progression of thyromegaly despite suppressive therapy. 3) Historic or physical findings suggest a malignancy, e.g., irradiation, multiple endocrine adenomatosis (MEA) syndrome, nerve paralysis, pain, tracheal compression, stipple calcification and cervical lymph node enlargement. 4) Indeterminant findings on cutting needle biopsy, e.g., lymphoma versus thyroiditis. Rarely, an operation is required for an oppressive goiter or associated hyperthyroidism.
在手术标本中,慢性(桥本氏)甲状腺炎的发生率相对较高,即在汇总研究中为13%,对于一种具有足够特异性临床和实验室特征的疾病而言,很少需要进行甲状腺切除术来诊断或治疗。这种发生率大概与区分甲状腺炎和甲状腺肿瘤的困难有关。回顾了1875年至1980年间在北卡罗来纳纪念医院针对甲状腺优势肿块进行的260例甲状腺切除术的经验,以确定诊断标准的可靠性和手术治疗的指征。采用临床检查标准,并辅以实验室检查,如游离甲状腺素指数、甲状腺自身抗体、促甲状腺激素水平、甲状腺扫描,此外明智地使用切割(芯)针活检程序,该系列中桥本氏甲状腺炎的发生率为3%,癌症为27%。4例患者的桥本氏甲状腺炎与另一需要进行甲状腺切除术的疾病并存。7例患者仅因桥本氏甲状腺炎而构成手术指征。这些患者的手术指征为:自主功能伴轻度甲状腺功能亢进(2例);伴有冷结节(2例);对抑制治疗无反应的甲状腺肿大(2例);以及迅速增大的肿块,类似肿瘤(1例)。71例高分化癌患者中只有1例患有桥本氏甲状腺炎。1例桥本氏甲状腺炎患者伴有淋巴瘤。在大多数患者中,使用适当的临床和实验室标准即可识别桥本氏甲状腺炎,无需进行甲状腺切除术来区分甲状腺炎和肿瘤。对于疑似或确诊为慢性甲状腺炎的患者,手术指征如下:1)存在优势肿块,抑制治疗后未完全消退。2)尽管进行了抑制治疗,甲状腺肿大仍进展。3)病史或体格检查结果提示恶性肿瘤,如放疗史、多发性内分泌腺瘤病(MEA)综合征、神经麻痹、疼痛、气管受压、点状钙化和颈部淋巴结肿大。4)切割针活检结果不明确,如淋巴瘤与甲状腺炎。很少情况下,因压迫性甲状腺肿或相关甲状腺功能亢进需要进行手术。